Fennec Pharmaceuticals (RV41.F) Q4 2025 Earnings

13NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.12
-0.08
-0.05
-0.02

Details

Expected EPS
-0.0189778932516
Actual EPS
-0.0173226218674
Surprise EPS
0
Surprise Percent
+8.72%

Description

Fennec Pharmaceuticals (RV41.F) has reported earnings of -0.0173226218674 per share for Q4 2025.

0 Comments

Share your thoughts